🚀Wanbury Climbing on Innovation. Watch out!

🧪 Product Launch – C RED: A next-gen Liposomal Iron formulation designed to manage anemia more effectively. ✅ Key Benefits of C RED: Enhanced absorption No metallic aftertaste Minimal digestive issues Safe for long-term use in pregnant women and iron-deficient patients 🌍 Market Response: Rolled out in Northern & Southern India, receiving strong doctor support and robust early sales. 📦 Expansion Plan: Pan-India distribution ramp-up in the next few months, driven by initial success. 🏭 Company Strength: Among India’s Top 50 pharma companies (ORG-IMS) with solid API exports and branded formulations. 📊 Ownership: Promoter holding stands at 39.76%, with growing non-institutional interest. What do you think of this one? Comment below.